MVF annual congresses

Anmeldeschluss ist der 23.11.2026! Der 15. MVF-Fachkongress „Primärversorgung 2030: Implementierung und Verbindlichkeit“ ist der Nachfolgekongress zum letztjährigen 14. MVF-Fachkongress „Agenda 2030: Primärversorgung gestalten“, erneut in Kooperation mit dem DNVF e.V. Er findet am …

The 14th MVF specialist congress „Agenda 2030: Shaping Primary Care“ (in cooperation with DNVF eV) took place on November 28, 2025, in the Scharoun Hall of the AOK Nordost in Berlin. Participation was made possible thanks to the commitment of our advisory board members and the special support of the congress sponsor, MSD…

The 13th MVF Conference "With PROM and PREM to Patient-Centered Care" took place on December 9, 2024, in the Alliance Room of AOK Nordost in Berlin. Thanks to the support of our advisory boards, we are able to make all content available open access and absolutely free of charge. Thank you very much for that. If you too...

12th MVF Conference "Pandemic Impact on Healthcare: Effects and Consequences of the Pandemic on Healthcare (Part 1) – Findings from Healthcare Research (Part 2)." The conference took place online.

The aim of the “catalog of priorities for health services research”, which was to be agreed upon jointly, was to identify the most important topics that health services research has to develop in order to improve our health system in the long term. Part 2 took place in the morning of January 24th, 2023.

The "Prioritization Catalogue for Health Services Research," which is to be agreed upon jointly, is intended to identify the most important topics that health services research needs to address in order to sustainably improve our healthcare system. Due to diverse feedback—heavy workload, deadlines close to...

The journal "Monitor Versorgungsforschung," which has served as a link between science and practice for 14 years, will host its 10th conference on December 7 and 8, 2021, from 3:00 PM to 6:30 PM. German health services research is...

For the assessment of the benefits of medicinal products for the treatment of rare diseases, in the case of conditional approvals and approvals under exceptional circumstances, the Federal Joint Committee (G-BA) is granted the authority, under the Act for Greater Safety in Pharmaceutical Supply (GSAV), to require pharmaceutical companies to...

The results of RCTs are commonly used, and so far unquestioned, as the basis for early benefit assessments, but also for many other research questions, such as political system decisions. This is probably correct, because RCTs are at least "the least error-prone for the question of benefit..."

The Innovation Fund will ensure that the projects it manages, should they be positively evaluated, can be transferred into regular care. But what about projects that are not supported by the Innovation Fund and yet have a proven positive impact?

The "Prioritization Catalogue for Health Services Research," which is to be agreed upon jointly, is intended to identify the most important topics that health services research needs to address in order to sustainably improve our healthcare system. Due to diverse feedback—heavy workload, deadlines close to...